RNAM

Avidity Biosciences

Delisted

RNAM was delisted on the 26th of February, 2026.

1 hedge funds and large institutions have $236K invested in Avidity Biosciences in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 333 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SL
301
Salomon & Ludwin
Virginia
RIL
302
Rothschild Investment LLC
Illinois
AAP
303
Arax Advisory Partners
Colorado
CAL
304
Capital Analysts LLC
Pennsylvania
EWA
305
EverSource Wealth Advisors
Alabama
PWMG
306
Private Wealth Management Group
New Jersey
PFBT
307
Parkside Financial Bank & Trust
Missouri
CA
308
Centerpoint Advisors
Massachusetts
MAM
309
Meeder Asset Management
Ohio
RFP
310
Root Financial Partners
California
BIA
311
Bell Investment Advisors
California
BFS
312
Bare Financial Services
Pennsylvania
TFA
313
Transamerica Financial Advisors
Florida
SS
314
SBI Securities
Japan
Northwestern Mutual Wealth Management
315
Northwestern Mutual Wealth Management
Wisconsin
TWD
316
True Wealth Design
Ohio
MAM
317
Marquette Asset Management
Minnesota
CFM
318
Cornerstone Financial Management
Massachusetts
TCM
319
TD Capital Management
Tennessee
TC
320
Truvestments Capital
Florida
ZBNA
321
Zions Bancorporation, National Association
Utah
RWM
322
Rialto Wealth Management
New York
FFO
323
Fortitude Family Office
Arizona
RS
324
Rakuten Securities
Japan
APW
325
Atlantic Private Wealth
North Carolina